What's new

Human medicines European public assessment report (EPAR): Beyfortus, nirsevimab, Date of authorisation: 31/10/2022, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Beyfortus, nirsevimab, Date of authorisation: 31/10/2022, Revision: 11, Status: Authorised

Feb 14, 2025 - 16:42
 0
Human medicines European public assessment report (EPAR): Beyfortus, nirsevimab, Date of authorisation: 31/10/2022, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Beyfortus, nirsevimab, Date of authorisation: 31/10/2022, Revision: 11, Status: Authorised
Read More

Tags:

Previous Article

Spirit Airlines Rejects Frontier Airlines’ Revised Acquisition Offer, Focuses on...

Next Article

Burberry unveils its Summer 2025 Campaign, ‘It’s Always Burberry Weather: London...

Related Posts

List of medicines currently in PRIME scheme

Feb 9, 2025  0

EMEA-003469-PIP01-23

EMEA-003469-PIP01-23

Feb 13, 2025  0

Non-clinical Working Party

Non-clinical Working Party

Feb 9, 2025  0